Skip To Main Content
Simone Thomas on Muck Rack

Simone Thomas

Los Angeles
As seen in: CNN, Yahoo Entertainment, Yahoo Life, Nature, The Telegraph, Wiley Online Library, E! News, E! News Canada, PS, Yahoo and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Simone

Contact Simone, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Bi‐ and Mono‐Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy

|
By Evan Reynolds, Peter Todd, Simone Thomas
| Wiley Online Library Verified
Open in Who Shared Issue with article?

Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration

|
By Simone Thomas, Aysel Cetinkaya-Fisgin, Xindan Hu, Remi Ben-Davies
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. References 1 and , “Lessons From Injury: How Nerve Injury Studies Reveal Basic Biological Mechanisms and Therapeutic Opportunities for Peripheral Nerve Diseases,” Neurotherapeutics 18 (2021): 2200–2221.
Open in Who Shared Issue with article?

The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type

|
By Long Davalos, Brian C Callaghan, Lavanya Muthukumar, Simone Thomas
| Wiley Online Library Verified
1 Introduction Diabetes mellitus (DM) is the most common cause of peripheral neuropathy (PN), accounting for nearly half of all cases [1]. Further, diabetic peripheral neuropathy (DPN) affects nearly 50% of individuals with DM [2-4]. DPN is the fifth most common cause of neurological disability worldwide [5] and is associated with significant health care costs. The global health expenditure in 2021 due to DPN was $966 billion [6], while annually in the United States, DPN costs $10 billion [7].
Open in Who Shared Issue with article?
See all 46 licensed articles (47 Total)